FewerJobs.
All jobs

Executive Director, Global Marketing, PDAC Cancer Strategy & Ops

Revolution Medicines - Remote (United States)

Posted Nov 9, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Nov 20, 2026
Salary
$252K-$315K From the posting source checked Nov 18, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$93,011 U.S. median for this role
Projected growth (BLS Employment Projections)
+5.1% - Faster than average

205% above the BLS role benchmark for marketing aggregate.

Posted salary is far from this role benchmark; treat it as low confidence.

Matched to SOC 13-1161 - Marketing aggregate by role bucket.

Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.

Role

Role function
Marketing From the posting source checked Nov 18, 2026
Seniority
Director Plus From the posting source checked Nov 18, 2026
Work mode
Remote From the posting source checked Nov 18, 2026
In-office days
0 days From the posting source checked Nov 18, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Nov 18, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Executive Director, Global Marketing, PDAC Cancer Strategy & Ops Remote (United States) Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity We are hiring an Executive Director of Global Commercial Development, reporting to VP Pancreatic Cancers. The role will work within a growing and fluid Global Commercial Development organization. Roles will continuously evolve as the team grows and portfolio priorities shift across multiple indications and assets. The role will have 2-3 direct reports. This position can be based out of Redwood City (CA), Plainsboro (NJ) or remote. Responsibilities often include: - Disease Area Strategy (DAS): Partner with clinical, commercial, medical, access and others to ensure DAS evolves and priorities shift based on latest evidence (internal, competitive). Support prioritization of future assets for development, in-licensing, or combinations. Partner with BD. Be an integrator and conduit of sharing commercial and clinical insights across functions. - Multi-year Global Commercialization Plan: Partner

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.

Apply at revmed.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs